USE OF (R)-IBUPROFEN METHANESULFONAMIDE AND SALTS THEREOF FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITION USEFUL IN THE TREATMENT AND PREVENTION OF REJECTION REACTIONS OF TRANSPLANTED ORGANS
The use of (R)-ibuprofen methanesulfonamide is described for the preparation of medicaments for the treatment and prevention of functional injury resulting from rejection reactions of transplanted organs. In particular, the use of non-toxic salts of (R)-ibuprofen methanesulfonamide, such as the (L)-lysine salt, is described for the prevention and the treatment of rejection reactions of transplanted kidneys.